Medical Research News and Research

RSS

Researchers discover cells responsible for resistance to T-ALL treatment

T-cell acute lymphoblastic leukemia (T-ALL) is a cancer of the blood that affects mainly children, but also less frequently adults. In adults, although the response to treatment might be initially positive, relapses are common and have a poor prognosis.

17 Dec 2020

Mogrify solidifies IP position surrounding core technology and expands platform algorithm to enhance cell conversion

Mogrify today announced it had secured the assignment of the foundational intellectual property underpinning its core direct cell conversion technology.

17 Dec 2020

Researchers identify key gene necessary for cells to consume and destroy viruses

A team led by UT Southwestern researchers has identified a key gene necessary for cells to consume and destroy viruses. The findings, reported online today in Nature, could lead to ways to manipulate this process to improve the immune system's ability to combat viral infections, such as those fueling the ongoing COVID-19 pandemic.

17 Dec 2020

Researchers examine proteins involved in SARS-CoV-2 infection

Like all viruses, the novel coronavirus is dependent on help from the human host cell. Proteins are the functional units of the cell and enable the virus to enter the host cell or help the virus to replicate.

17 Dec 2020

FDA grants EUA for new COVID-19 viral antigen test

The U.S. Food and Drug Administration granted emergency use authorization (EUA) today for an innovative COVID-19 viral antigen test developed with support from the National Institutes of Health's Rapid Acceleration of Diagnostics (RADx) Initiative.

16 Dec 2020

New study to evaluate health outcomes of SARS-CoV-2 infection in children

An observational study has launched to evaluate the short- and long-term health outcomes of SARS-CoV-2 infection in children, including multisystem inflammatory syndrome in children (MIS-C), and to characterize the immunologic pathways associated with different disease presentations and outcomes. SARS-CoV-2 is the virus that causes COVID-19.

16 Dec 2020

SwRI is developing machine vision tool to improve military medical training

Southwest Research Institute is developing a machine vision tool to help the U.S. Department of Defense assess the biomechanical movements of military medical personnel during training exercises.

16 Dec 2020

Discovery about DNA repair enzyme could lead to new treatments for certain cancers

Researchers at the Francis Crick Institute have found a new way to prevent some tumours from repairing their own DNA, a function that is essential for cancer cell survival.

16 Dec 2020

Reports of drinking bleach to prevent COVID-19 skewed by "problematic" claims

Researchers in the United States have conducted studies suggesting that reports of people ingesting household cleaning agents as a way of protecting against coronavirus disease 2019 (COVID-19) are skewed by "problematic" responses to surveys.

15 Dec 2020

Surgical and drug treatment approaches are equally effective for diabetic eye disease

Surgical and injectable drug approaches are equally effective for treatment of bleeding inside the eye from proliferative diabetic retinopathy (PDR), according to a National Eye Institute (NEI)-supported clinical study from the DRCR Retina Network (DRCR.net).

15 Dec 2020

Drug may increase vaccine protection in older adults

A drug that boosts the removal of cellular debris in immune cells may increase the protective effects of vaccines in older adults, a study published today in eLife shows.

15 Dec 2020

SIMON – The Machine Learning Platform Paving the Future of Vaccine Development

A machine learning algorithm developed by the Oxford Vaccine Group promises more effective vaccine development for several diseases, including COVID-19.

15 Dec 2020

Study provides valuable interaction about animal host and pathogen during pneumococcal infections

Researchers at the University of Maryland School of Medicine published one of the most comprehensive analyses of how genes get expressed during infection (known as a transcriptome). The analyses include three different strains of the bacteria Streptococcus pneumoniae, which causes pneumonia, meningitis, and middle-ear infections.

15 Dec 2020

Research breakthrough dispels concerns that human stem cells contain cancer-causing mutations

Pioneering new research has made a pivotal breakthrough that dispel concerns that human stem cells could contain cancer-causing mutations.

14 Dec 2020

MIPT researchers use zebrafish to study chronic stress

A team of researchers led by MIPT's Allan Kalueff has studied chronic stress in zebrafish and determined that the animal can serve as a valuable model species for research into the associated brain diseases, complementing research currently done on rodents.

14 Dec 2020

Remdesivir likely to be highly effective treatment for COVID-19

The drug remdesivir is likely to be a highly effective antiviral against SARS-CoV-2, according to a new study by a team of UK scientists.

14 Dec 2020

Study reveas how the brain uses neural activity patterns to compare expectations with the present

Imagine you are sitting on the couch in your living room reading. You do it almost every night. But then, suddenly, when you look up you notice this time something is different.

14 Dec 2020

Vitamin D deficiency could explain why autism spectrum disorder is more common in boys

A deficiency in Vitamin D on the mother's side could explain why Autism spectrum disorder is three times more common in boys, say researchers from The University of Queensland.

11 Dec 2020

Study uncovers genetic risks of Takayasu arteritis

In a paper published today in the American Journal of Human Genetics, a group of international collaborators led by researchers from the University of Pittsburgh School of Medicine identified new genetic associations that can predict individual susceptibility to a rare inflammatory disease called Takayasu arteritis.

11 Dec 2020

Combination of baricitinib and remdesivir could benefit some COVID-19 patients

The combination of baricitinib, an anti-inflammatory drug, and remdesivir, an antiviral, reduced time to recovery for people hospitalized with COVID-19, according to clinical trial results published in the New England Journal of Medicine.

11 Dec 2020

Medical Research News and Research

Researchers discover cells responsible for resistance to T-ALL treatment

Mogrify solidifies IP position surrounding core technology and expands platform algorithm to enhance cell conversion

Researchers identify key gene necessary for cells to consume and destroy viruses

Researchers examine proteins involved in SARS-CoV-2 infection

FDA grants EUA for new COVID-19 viral antigen test

New study to evaluate health outcomes of SARS-CoV-2 infection in children

SwRI is developing machine vision tool to improve military medical training

Discovery about DNA repair enzyme could lead to new treatments for certain cancers

Reports of drinking bleach to prevent COVID-19 skewed by "problematic" claims

Surgical and drug treatment approaches are equally effective for diabetic eye disease

Drug may increase vaccine protection in older adults

SIMON – The Machine Learning Platform Paving the Future of Vaccine Development

Study provides valuable interaction about animal host and pathogen during pneumococcal infections

Research breakthrough dispels concerns that human stem cells contain cancer-causing mutations

MIPT researchers use zebrafish to study chronic stress

Remdesivir likely to be highly effective treatment for COVID-19

Study reveas how the brain uses neural activity patterns to compare expectations with the present

Vitamin D deficiency could explain why autism spectrum disorder is more common in boys

Study uncovers genetic risks of Takayasu arteritis

Combination of baricitinib and remdesivir could benefit some COVID-19 patients

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News